Terbinafine

Longterm Use of Oral Antifungal Terbinafine in a Case of

Superficial Dermatophytosis

250mg) 32

97042

Lisim

96 11
95 1 8 15
1 Lisim(terbinafine

38

96 1 97 5
LISIM TABLETS
:A043575100 37
90

25

96 1 97 5 LISIM TABLETS

(%)

37

29

26

89.66

20

20

18

90.00

100.00

100.00

0.00

Lisim

2.
()

10.6.4 LamisilTerbinafine

1.

250mg

(2))

12 6

12

Lisim 32

2.

3. Terbinafine

10.5%

5.3%

1.

0.046%.(3)

terbinafine ( Lisim)

terbinafine NDiaye

Malassezia furfur

24-48

MIC (1)

500mg terbinafine

23 3

neutropenia (900-1070/mm3)1

26

AST/ALT 329/359 Ul/L)

(4)

ketoconazole

fluconazole

1. Nimura K, Niwano Y, Ishiduka S,

Fukumoto R, (2001). Comparison of in

vitro antifungal activities of topical

antimycotics, launched in 1990s in Japan,

Int J Antimicro Agents 18: 173178

2. Glyn E, Evans V, Sigurgeirsson B (1999)

Double blind, randomised study of

continuous terbinafine compared with

intermittent itraconazole in treatment of

toenail

10311035.

onychomycosis

3. O'Sullivan

DP

(1999).

BMJ.

318:

Terbinafine:

tolerability in general medical practice.

Br J Dermatol

141 (suppl 56): 21-25.

4. NDiaye B, Dieng MT, Perez A, et al

(2006). Clinical efficacy and safety of

oral terbinafine in fungal mycetoma; Int J

Dermat, 45, 154157,

38

5.
27